JP Patent
JP6704058B2 — プロテアーゼ阻害剤の長時間作用性医薬組成物
Assigned to Taimed Biologics Inc · Expires 2020-06-03 · 6y expired
What this patent protects
Patent listed against Vocabria.
Drugs covered by this patent
- Vocabria (CABOTEGRAVIR) · GSK
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.